Company
Our Story
Cibus Therapeutics, a clinical-stage biotech company based in Palo Alto, California, was established with a visionary goal: to transform the treatment of inflammatory gastrointestinal diseases through pioneering small-molecule therapies. By integrating advanced molecular insights with a robust clinical pipeline, we aim to disrupt disease progression and offer meaningful relief. Our collaborative approach, rooted in Silicon Valley’s innovation ecosystem, positions us to redefine care standards and bring hope to patients worldwide.
Our Approach
At Cibus Therapeutics, we leverage cutting-edge drug discovery and clinical development platforms to advance our innovative small molecule therapy, designed to target the complex inflammatory signaling cascades driving pancreatitis and inflammatory bowel disease (IBD). By integrating advanced translational research with deep clinical expertise, we streamline the development of safe, effective treatments that address critical unmet needs. Our collaborative approach fosters strategic partnerships with leading organizations, such as Mission Cure, to accelerate scientific breakthroughs and deliver transformative therapies to patients worldwide.
Our Commitment
Innovation
At Cibus Therapeutics, we are trailblazers in developing a novel small molecule therapy that targets the intricate inflammatory pathways of chronic pancreatitis (CP) and inflammatory bowel disease (IBD). Our cutting-edge approach harnesses advanced scientific platforms to create transformative treatments that address the urgent needs of these underserved conditions.
Patient-Centricity
Our work is driven by a deep commitment to improving the lives of patients suffering from debilitating gastrointestinal diseases. We design therapies with a focus on alleviating pain, restoring function, and enhancing quality of life, ensuring every step of our process prioritizes the needs and experiences of those we serve.
Collaboration
We believe in the power of partnership to accelerate progress. By forging strategic alliances with leading organizations, such as Mission Cure, and engaging with global research and clinical communities, we drive scientific discovery and expedite the delivery of life-changing therapies to patients worldwide.
Integrity
Our pursuit of groundbreaking treatments is grounded in unwavering ethics and transparency. We uphold the highest standards of scientific rigor, regulatory compliance, and accountability, ensuring trust and excellence in everything we do.
